Sedergine

Quick links to important sections

Sedergine

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sedergine

Quick Facts

Property Description
Active ingredient Acetylsalicylic acid (ASA)
Form Effervescent or Soluble Tablets
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common purpose Relief of general pain, fever, and inflammation
Origin Synthetic derivative of salicylic acid

What Type of Medicine is Sedergine?

Sedergine is a medicinal preparation containing the single active component Acetylsalicylic acid (ASA), which is universally recognized as Aspirin. It is chemically categorized as a synthetic acyl derivative of salicylic acid and constitutes a single-ingredient product. The drug belongs to the clinically recognized pharmacological group of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), a classification that dictates its primary functions in the body. Unlike standard solid-dose Aspirin products, Sedergine is specifically differentiated by its effervescent formulation, which is engineered to target patients seeking rapid relief from general symptomatic discomforts, such as headache or fever.

Composition, Form, and General Purpose

The medication is formulated for oral administration and is typically presented as effervescent or soluble tablets, requiring dissolution in water before ingestion. This pharmaceutical form, consisting of the active ASA and specialized excipients, is designed to provide a readily available solution for consumption. The general therapeutic purpose of Sedergine is to mitigate common physical discomforts related to pain, fever, and inflammation. Its fundamental mechanism involves the irreversible inhibition of the cyclooxygenase (COX) enzyme system. This core property allows the drug to effectively reduce elevated body temperature and minor muscular aches, ensuring the primary benefit is symptomatic relief across these domains.

Regulatory References

  1. Aspirin
  2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  3. [NIH PubChem]
  4. [MedlinePlus]

What side effects are possible with Sedergine?

Possible Side Effects and Safety Information

Adverse reactions associated with Sedergine (acetylsalicylic acid) are formally documented based on their System Organ Class (SOC) and frequency of occurrence in regulatory documents.

Adverse Reaction Scope

Common adverse reactions (occurring in 1% to 10% of patients) primarily affect the Gastrointestinal SOC and include dyspepsia (indigestion) and increased bleeding tendencies. The risk of these gastrointestinal effects is noted to be higher with increasing doses.

Rare adverse reactions (occurring in 0.01% to 0.1% of patients) include hypersensitivity reactions, such as anaphylactic shock and angioedema. Other rare effects involve the Blood and lymphatic system, like aplastic anemia or thrombocytopenia. At high doses, signs of salicylism, such as tinnitus (ringing in the ears) or impaired hearing, may occur.

Serious Adverse Reactions and Restrictions

Serious adverse reactions documented in official sources include gastrointestinal bleeding, ulceration, and perforation, which may be fatal. Severe allergic reactions are also classified as serious events.

Safety profiles establish contraindications, restricting use in patients with a known hypersensitivity to the drug or other non-steroidal anti-inflammatory drugs (NSAIDs), active or recurrent peptic ulcers, or severe organ failure (renal, hepatic, or heart failure).

Population-specific safety considerations are also defined:

  • Children and Adolescents: Acetylsalicylic acid is linked to the risk of Reye's syndrome, a rare but serious illness, when administered to children and teenagers with viral infections (e.g., chickenpox or flu-like symptoms).
  • Pregnancy: The medicine is contraindicated during the last three months of pregnancy due to documented risks to the fetus.
  • Elderly Patients: This population has an increased frequency of adverse reactions, particularly serious gastrointestinal bleeding and perforation.

Overdose and Emergency Response

Overdose and when to seek help

Sedergine often contains Acetylsalicylic Acid (Aspirin), meaning an overdose carries the risk of Salicylate Intoxication, which can be life-threatening and requires immediate emergency medical attention.

Documented Overdose Symptoms

The physiological effects of overdose are classified based on severity and the time of exposure (acute vs. chronic):

Classification Manifestations Described in Official Documents
Mild to Moderate Toxicity Tinnitus (ringing in the ears), nausea, vomiting, rapid breathing (tachypnea), hyperpnea, and gastrointestinal upset.
Severe Toxicity Development of severe metabolic disturbances, including metabolic acidosis, hyperthermia (fever), significant fluid and electrolyte imbalances, and severe neurological signs such as seizures, coma, and cerebral or pulmonary edema.

Chronic Overdose Risk

Chronic overdose, resulting from repeated high doses or accumulation in the body, may present subtly, especially in older adults. Symptoms are often neurological, including confusion, agitation, and delirium, without the initial pronounced GI upset or tinnitus seen in acute cases.

Emergency Actions and When to Seek Help

If an overdose is known or suspected, do not wait for symptoms to appear or worsen. Immediate medical assistance is required. Contact the local emergency services or a national Poison Control Center right away. Urgent help is especially critical if the person is unconscious, experiencing convulsions, or struggling to breathe. Timely intervention is essential to prevent irreversible complications.

Therapeutic Uses of Sedergine

Sedergine contains acetylsalicylic acid (ASA), a medication with established therapeutic uses. Its primary function focuses on providing symptomatic relief and, in specific medical applications, helping to reduce the risk of certain serious health events.

ASA is used to help manage symptoms such as fever, mild to moderate aches, pain, and inflammation. This encompasses relief for common conditions like headache, toothache, minor arthritis discomfort, and symptoms associated with the common cold. The medication helps by temporarily easing these symptoms, offering the benefit of improved comfort.

“This medication is used to relieve pain and fever, and serves as an anti-inflammatory agent.”

Furthermore, for specific individuals and indications, it is prescribed for its function in helping to reduce the risk of certain cardiovascular events, such as myocardial infarction or ischemic stroke.

Quick Fact: Relief for Headaches Sedergine is used to help temporarily ease the discomfort associated with tension headaches.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Sedergine, which contains the active ingredient Acetylsalicylic Acid (ASA), is generally indicated for pain relief and fever reduction in adults and adolescents over 16 years old. However, its use is strictly contraindicated in several patient groups due to the risk of serious side effects.


Who Can Use Sedergine (General Indications)

  • Adults: For symptomatic relief of mild to moderate pain and/or fever.
  • Adolescents (Over 16 years): For short-term treatment of pain and fever, following medical advice.

Who Should NOT Use Sedergine (Contraindications)

Condition/Patient Group Reason for Contraindication
Children and Adolescents under 16 Risk of Reye's Syndrome (especially with viral infections).
Allergy to Salicylates/NSAIDs Risk of hypersensitivity reactions (asthma, angioedema).
History of Gastrointestinal Bleeding/Ulcers ASA can exacerbate bleeding and GI mucosal damage.
Severe Liver, Kidney, or Heart Failure Risk of worsening organ function.
Last Trimester of Pregnancy Risk of fetal and maternal complications (e.g., premature closure of the ductus arteriosus).
Taking Methotrexate (>15 mg/week) Increased methotrexate toxicity.
Haemorrhagic Diathesis Increased risk of bleeding due to ASA's antiplatelet effect.

What should I know about interactions with other medicines?

Sedergine (Acetylsalicylic acid/ASA) has officially documented interaction patterns primarily concerning its effects on hemostasis and clearance mechanisms. Co-administration with oral anticoagulants (e.g., Warfarin, Heparin) and other antiplatelet agents significantly elevates the risk of hemorrhage and major bleeding events due to pharmacodynamic interference with blood clotting. This bleeding risk is also reinforced when ASA is combined with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Selective Serotonin Reuptake Inhibitors (SSRIs), or Corticosteroids, increasing the documented hazard of gastrointestinal (GI) ulceration.


Interaction Constraints and Restrictions

The co-administration of high-dose Methotrexate (ge 15 mg/week) is a formal contraindication, as ASA inhibits its renal clearance, which can lead to clinically significant elevated serum levels and potential toxicity. Furthermore, ASA may increase the serum concentrations of both Lithium and Digoxin due to reduced renal excretion. Chronic, heavy alcohol use is documented to increase the risk of severe GI bleeding.

A specific timing-separation rule is required for non-selective NSAIDs like Ibuprofen to maintain ASA's intended antiplatelet function; Ibuprofen should not be taken within 8 hours before or 30 minutes after an immediate-release ASA dose. Elderly patients and those with renal impairment have a higher documented risk for serious GI events when co-administering ASA with certain antihypertensives.

Mechanism of Action

The mechanism of action for Sedergine is determined solely by its active component, Acetylsalicylic acid (ASA), which functions as a unique irreversible inhibitor of the Cyclooxygenase ( COX) enzyme system. ASA exerts its effect by forming a stable covalent bond with a serine residue in the active site of both the COX-1 and COX-2 isoforms. This chemical modification permanently inactivates the enzyme, blocking the conversion of arachidonic acid into prostanoids.

This molecular cascade leads to several distinct physiological modulations. Centrally, the inhibition of COX-2 in the hypothalamus prevents the production of PGE2, allowing the body's thermoregulatory center to restore its set point and initiate heat-loss responses. Peripherally, the suppression of prostaglandins at injury sites reduces the chemical sensitization of nociceptors (pain-sensing nerve endings). This change results in the physiological elevation of the nociceptive pain threshold. Furthermore, the irreversible inhibition of COX-1 in non-nucleated platelets suppresses TXA2 synthesis, affecting platelet aggregation for their entire lifespan.

Dosage and Administration Information

How to Use Sedergine: General Administration Guidelines

Sedergine, as an effervescent form of Acetylsalicylic acid (ASA), is administered via the oral route and requires specific preparation for proper use. The protocol emphasizes a standardized approach to dose preparation and scheduling, detailed across prescribing information.


Official Administration Protocol

Feature Official Instructions
Route of administration Oral route only, following complete dissolution in water.
Dosing schedule Single dose ranges from 325 mg to 1000 mg ASA. The maximum daily dose (24 hours) is constrained to approximately 3900 mg to 4000 mg ASA.
Timing in relation to meals Must be taken with or immediately after a meal or with a full glass of water.
Preparation requirements The tablet must be completely dissolved in a full glass of water before ingestion.
Age-group rules Generally restricted in children under 12 years of age. Some labels advise a lower maximum daily dose for older adults (the elderly).

Frequency and Procedural Constraints

The usage pattern for Sedergine is structured as as-needed (intermittent use). The dose may be repeated after a minimum interval of at least 4 hours, with the total dosage adhering to the established 24-hour maximum limit. Importantly, official instructions limit continuous self-administration to 3 days for fever or 3 to 4 days for pain. If a dose is missed, guidance advises taking only the next scheduled dose at the usual time, without doubling the amount.

This protocol defines the standardized, short-term usage for the medicine, requiring specific dissolution steps and adherence to time-bound dosing limits.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Key Research Findings

Sedergine contains acetylsalicylic acid (ASA), commonly known as aspirin. Research has investigated the compound's characteristics as an analgesic (pain reliever), antipyretic (fever reducer), and anti-inflammatory agent. Clinical evidence indicates that studies have explored its effect on outcomes in various acute pain and fever conditions.

Detailed Study Analysis

1. Efficacy in Pain and Fever Management

A meta-analysis of randomized controlled trials (RCTs) examined the use of ASA for acute pain, including tension-type headaches and pain associated with upper respiratory tract infection (URTI). The primary endpoint in many studies involved measuring subjective pain relief or the change in body temperature.

  • Headache: Single-dose studies found that acetylsalicylic acid was associated with a greater proportion of participants achieving pain relief compared to placebo in cases of moderate to severe tension-type headache.
  • Fever: In patients with acute febrile URTI, studies reported that acetylsalicylic acid at 1000 mg demonstrated a greater reduction in body temperature compared to placebo, with efficacy similar to that reported for paracetamol (acetaminophen) at the same dose.

2. Comparison to Other Analgesics

Research has explored the tolerability of ASA in comparison to other over-the-counter (OTC) analgesics. One large-scale tolerability study examined patients with mild to moderate pain due to cold/flu symptoms or sore throat.

  • Adverse Events: The study reported that participants taking ASA had a higher rate of significant adverse events, particularly gastrointestinal events, compared to those taking ibuprofen or paracetamol.

3. Investigational Use and Limitations

Studies have also examined ASA in combination with other drugs for various investigational purposes, including in specific cancer treatment protocols. This research is generally conducted in clinical trial settings under close supervision. Data regarding the long-term safety of ASA for primary prevention among older individuals without established cardiovascular disease highlights the need to balance potential benefit against the risk of bleeding events. Further investigation is needed to clarify the clinical relevance of these findings across different patient populations.

Frequently Asked Questions (FAQ)

Common questions about Sedergine (FAQ)


Q: What is the difference between Sedergine and paracetamol?

A: Sedergine contains acetylsalicylic acid (ASA), which is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). According to official studies, ASA and paracetamol, which belongs to a different pharmacological class, have been compared for their effectiveness in relieving fever. The two medicines differ in their primary mechanism of action.


Q: Is Sedergine considered a blood thinner?

A: The active ingredient in Sedergine, acetylsalicylic acid, is officially described as an antiplatelet agent. This means that, based on its mechanism of action, it affects the ability of blood to form clots. This property is the basis for official warnings concerning the potential for bleeding events.


Q: Can Sedergine be taken with medicines for colds and flu?

A: Official documents caution that Sedergine should not be taken with other non-steroidal anti-inflammatory drugs (NSAIDs), which are common active ingredients found in some cold and flu preparations. Combining these medicines is documented to increase the potential for side effects. For this reason, the official information advises caution regarding co-administration.


Q: Does Sedergine interact with commonly prescribed medications like certain antidepressants?

A: According to official safety documents, co-administration of Sedergine with medications in the Selective Serotonin Reuptake Inhibitor (SSRI) class of antidepressants is documented to increase the hazard of gastrointestinal bleeding. This is a known interaction highlighted in the prescribing information.


Q: Are there special warnings for people with liver or kidney problems using Sedergine?

A: Official safety profiles strictly contraindicate the use of Sedergine in patients diagnosed with severe liver, kidney, or heart failure. Official documentation notes that patients with existing renal impairment may experience a higher frequency of adverse reactions, particularly serious gastrointestinal events.


Q: Does Sedergine interact with caffeine?

A: The active ingredient in Sedergine, acetylsalicylic acid, is sometimes formulated in combination with caffeine in other regulated pain relief products. Studies on the combination itself have been conducted, and it is documented that products containing both agents are commonly used for acute pain relief, such as headaches.


Q: Are there any known interactions between Sedergine and herbal supplements?

A: Official warnings caution against combining Sedergine with herbal supplements that are known to possess antiplatelet activity. This is because combining them is documented to increase the potential for bleeding. Examples of herbs sometimes associated with this activity include ginger or garlic.


Q: Does Sedergine contain sodium?

A: Yes, as Sedergine is an effervescent (dissolving) tablet, it typically contains sodium hydrogen carbonate (a type of sodium salt) as one of the inactive ingredients, or excipients. This excipient is necessary for the tablet to dissolve properly in water.


Q: Are there different strengths of Sedergine available?

A: Regulatory documents and product labels indicate that Sedergine is manufactured in different strengths of the active ingredient, acetylsalicylic acid (ASA), which may include formulations such as 500 mg or 1000 mg of ASA.


Q: Can Sedergine affect blood sugar levels?

A: Official warnings indicate that acetylsalicylic acid may increase the effect of certain medicines used to treat diabetes mellitus. This could result in changes to blood glucose levels if used concurrently with diabetes medication and not monitored.


Q: What is the role of lysine in Sedergine?

A: Sedergine is chemically formulated as the Lysine salt of acetylsalicylic acid (ASA). The lysine component is part of the overall formulation that is designed to support the rapid solubility and absorption of the active ingredient once dissolved in water.


Q: Is Sedergine known to cause drowsiness?

A: Drowsiness (or somnolence) is listed in regulatory safety documents as a possible, though typically uncommon or rare, central nervous system side effect associated with the use of acetylsalicylic acid.


Q: How is Sedergine different from other non-steroidal anti-inflammatory drugs (NSAIDs)?

A: The mechanism of action for Sedergine's active ingredient, ASA, makes it unique among most NSAIDs because it works as an irreversible inhibitor of the cyclooxygenase (COX) enzyme system. This irreversible action permanently affects platelet function for the lifetime of the platelet.


Q: What is the recommended approach if a side effect is noticed?

A: Patient Information Leaflets (PILs) attached to regulatory documents advise that if a side effect is noticed, especially one that is severe or appears to be a sign of an allergic reaction, official guidance recommends that the medicine's use is discontinued and a healthcare professional is consulted.


Q: What does the regulatory body say about using Sedergine while breastfeeding?

A: Regulatory documents state that low doses of acetylsalicylic acid are described as passing into breast milk in negligible amounts. However, official information advises that any use during this time requires caution and monitoring.


Q: Is Sedergine a prescription-only medicine?

A: Sedergine is generally categorized by regulatory bodies as an Over-The-Counter (OTC) medicine in many territories. It is intended for short-term symptomatic relief of pain and fever without a required prescription.


Q: Why is hydration mentioned when using effervescent medicines like Sedergine?

A: The official administration protocol requires the effervescent tablet to be completely dissolved in a full glass of water before ingestion. This instruction is necessary to ensure the proper and complete administration of the dose as intended by the manufacturer and regulatory bodies.

How should Sedergine be stored and disposed of?

Storage and Disposal of Sedergine

Sedergine, as an effervescent form of acetylsalicylic acid, must be stored according to regulatory requirements to maintain its stability and effectiveness.

Storage Requirement Official Condition (Label-Based)
Temperature Do not store above 25 C or 30 C (check specific label).
Protection Must be protected from light and moisture.
Container Keep in the original container and tightly closed.
Prohibited Do not store in a refrigerator or freeze.

All medicine must be kept out of the sight and reach of children.

Expired or unused Sedergine should be disposed of properly. Do not dispose of the medication via wastewater or household trash. The product should be returned to a pharmacy or a designated drug take-back program in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sedergine found in:

A-Z Index: